About 248,000 results
Open links in new tab
  1. At-Home OTC COVID-19 Diagnostic Tests | FDA

    Sep 16, 2025 · The table below is updated regularly and lists FDA-authorized at-home OTC COVID-19 diagnostic tests, who can use the test, links to home use instructions for each test, …

  2. Expiration Dating Extension | FDA

    Following initial FDA authorization, FDA has extended and authorized shelf-life expiration dates after reviewing real-time data generated by the IVD manufacturer.

  3. At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions …

    The FDA does not recommend using at-home COVID-19 diagnostic tests beyond their authorized expiration dates, which, as noted above, may go beyond the date printed on the box.

  4. COVID-19 Test Basics | FDA

    Complete and submit the report online through the FDA’s MedWatch website. Download the form or call 1-800-332-1088 to request a form, then complete and return to the address on the form …

  5. COVID-19 Tests Granted Marketing Authorization - FDA

    Feb 24, 2025 · The page lists the COVID-19 tests that were FDA reviewed for safety and effectiveness and authorized for marketing under traditional premarket authorities.

  6. Coronavirus Disease 2019 (COVID-19) | FDA

    Facts and news you can trust from the FDA about COVID-19 tests, treatments, and vaccines.

  7. FAQs on Testing for SARS-CoV-2 | FDA

    Nov 8, 2023 · Existing emergency use authorizations (EUAs) for devices relating to COVID-19 remain in effect under section 564 of the Federal Food, Drug, and Cosmetic Act.

  8. In Vitro Diagnostics EUAs | FDA

    Since the Secretary’s declaration under section 564 of the Federal Food, Drug, and Cosmetic Act related to in vitro diagnostic tests for COVID-19, on February 4, 2020, the FDA has granted …

  9. ACON Laboratories, Inc: Flowflex COVID-19 Antigen Home Test 21-month to 24-month self-life extension granted by the FDA on March 15, 2023

  10. In Vitro Diagnostics EUAs - Antigen Diagnostic Tests for SARS-CoV …

    Sep 3, 2025 · On November 1, 2022, the FDA revised the authorized uses and required updates to product labeling regarding repeat, or serial, testing, for all currently authorized SARS-CoV-2 …